author-photo

Jennifer Johnson

Thomas Jefferson University

67

Papers

455

Citations

Citation Trend

Filter By

Papers (50) Sort By

Journal Conference Others

Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma.

2021 Laryngoscope
Show All
- Source
- Cite
- Save
Citations (0)
Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.

2021 Head and Neck-journal for The Sciences and Specialties of The Head and Neck
Show All
- Source
- Cite
- Save
Citations (0)
Pathologic and radiographic responses in a window of opportunity for durvalumab plus metformin trial for squamous cell carcinoma of the head and neck (HNSCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1441: Predictors of treatment response in a preoperative window of opportunity trial of nivolumab in resectable squamous cell carcinoma of the head and neck

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
B08 Impact of Concurrent STK11 Loss and c-MYC Amplification in Metastatic Non-Small Cell Lung Cancer (NSCLC)

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)